The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 10709-10720

  Leight, E R ^a   Sugden, B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ORIP; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CELL CYCLE; CELL DIVISION; CELL LINE; CONTROLLED STUDY; DNA REPLICATION ORIGIN; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPLICON;

BINDING SITES; DNA REPLICATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; PLASMIDS; REPETITIVE SEQUENCES, NUCLEIC ACID; REPLICATION ORIGIN; REPLICON; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

EID: 0034755383     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.10709-10720.2001     Document Type: Article

References (62)

1. Replication of latent Epstein-Barr virus genomes in Raji cells
2. Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins
3. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element
4. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1
5. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA
6. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
7. A replication fork barrier at the 3′ end of yeast ribosomal RNA genes
8. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication
9. Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft
10. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study
11. Role of the EBNA-1 protein in pausing of replication forks in the Epstein-Barr virus genome
12. Stabilization of the EBNA1 protein on the Epstein-Barr virus latent origin of DNA replication by a DNA looping mechanism
13. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus
14. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication
15. Termination of mammalian rDNA replication: Polar arrest of replication fork movement by transcription termination factor TTF-I
16. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma
17. Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
18. Identification of EBNA1 amino acid sequences required for the interaction of the functional elements of the Epstein-Barr virus latent origin of DNA replication
19. DNA length, bending, and twisting constraints on IS50 transposition
20. Replication control of autonomously replicating human sequences
21. Transcription inhibits the replication of autonomously replicating plasmids in human cells
22. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus
23. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication
24. Selective extraction of polyoma DNA from infected mouse cell cultures
25. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein
26. Cell to cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells
27. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus
28. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus
29. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus
30. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx
31. Electroporation: Parameters affecting transfer of DNA into mammalian cells
32. Genetic analysis of the mitotic transmission of minichromosomes
33. Isolation of human sequences that replicate autonomously in human cells
34. Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: Implications of the nuclear import of plasmids
35. EBNA-1: A protein pivotal to latent infection by Epstein-Barr virus
36. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event
37. HeLa cells are phenotypically limiting in cyclin E/CDK2 for efficient human papillomavirus DNA replication
38. Initiation and termination of DNA replication in human rRNA genes
39. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells
40. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1
41. Infectious mononucleosis: Clinical manifestations in relation to EB virus antibodies
42. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication
43. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
44. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained
45. Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1
46. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
47. Identification of minimal oriP of Epstein-Barr virus required for DNA replication
48. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome
49. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus
50. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells
51. Replication and supercoiling of simian virus 40 DNA in cell extracts from human cells
52. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: Stabilization of an origin complex with Epstein-Barr nuclear antigen 1
53. EBV's plasmid replicon: An enigma in cis and trans
54. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis
55. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus
56. CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells
57. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
58. The minimal replicator of Epstein-Barr virus oriP
59. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells
60. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells